Ardelyx

IPO

Public · Fremont, United States · Founded 2007 · $140.0M raised

Employees
201–500
Founded
2007
Business Model
B2B
Total Funding
$140.0M
Last Round
$110.0M Private EquityJul 2016
Rounds
2
Type
Public

About

Ardelyx (Nasdaq: ARDX) is a biopharmaceutical company dedicated to developing first-in-class medicines that improve the lives of people living with kidney disease and gastrointestinal conditions. The company's lead approved product, XPHOZAH (tenapanor), is an FDA-approved treatment for hyperphosphatemia in adults with chronic kidney disease on dialysis.

Summary

Ardelyx is a Biopharmaceutical company based in Fremont, United States, founded in 2007. It has raised $140.0M in total across 2 rounds, most recently a $110.0M Private Equity round in Jul 2016. Investors include NEA, CMEA and Amgen.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Private EquityPrivate EquityJul 2016
$110.0M

Sign up to see all 3 rounds

Series B through Private Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ardelyx on Indexed.vc
<a href="https://indexed.vc/companies/ardelyx"><img src="https://indexed.vc/api/badge/company/ardelyx" alt="Ardelyx on Indexed.vc" width="260" height="76" /></a>